openPR Logo
Press release

Neurological Biomarkers Market To Hold a High Potential for Growth by 2025

Neurological Biomarkers Market To Hold a High Potential

Biomarkers are biological markers which measure the biological states. It is used for indicating the normal biological and pathogenic process to a therapeutic intervention. These biomarkers can also be used in combination to access disease state of an individual. Scientists are exploring more about the structural and functional differences of the neurological diseases. Moreover, there has been an increase in biobanks which have help address unmet needs in oncology, neuroscience, and cardiovascular disease.

The University of British Columbia and the Karolinska Institute in Sweden have set up biobanks that provide necessary resources and information for biomedical research. Alzheimer’s is the most common form of dementia affecting 12 million people. Neuroimaging and neuropsychological probes can help predict Alzheimer before behavioral tests diagnose. Thus pre-assessment tests such as Positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) are driving the demand for neurological biomarkers.

Neurological Biomarkers Market: Dynamics

The introduction of newer neurological biomarkers is expected to play a crucial role in helping neuropathologists in the characterization and selection of suitable treatment strategies. Moreover, with the advent of telehealth and personalized medicine, there is an emerging trend of single-cell biosensors as it may help integrating large-scale clinical and molecular information.

These biomarkers are used in patients suffering from acute ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage and traumatic brain injury. Recovery from such neurocritical disease depends on how well the patient mitigates. In such situations, procurement of imaging studies or a good examination may be delayed due to the complexities involved. This shortcoming has further fueled the demand for biomarkers. The market is also experiencing recent trends with the researches undertaken on novel radiotracers, miRNA, and integration of systems biology into routine biomarker validation.

Request for Table of Contents @ https://www.persistencemarketresearch.com/methodology/16303

The neurological market is expected to witness growth owing to the various technological developments, the expansion in application and rise in the incidence of neurological disorders such as Alzheimer's, Parkinson’s and stroke. But the industry has certain restraints such as reproduction of positive trial results, the absence of pre-analytical tests and failure to investigate the efficiency of the biomarker as compared to previous one.

Furthermore, the demand for these biomarkers is expected to propel as the demand for neurological care is increasing. In America, there are around 5.4 million people diagnosed with Alzheimer’s disease. The number is expected to triple to 16 million by 2050. The demand for procedural specialties is more as compared to on procedural specialties. This statement can be justified by the fact that the Medicare payment grew by 84% for procedural specialties and only 48% for non-procedural specialties.

Neurological Biomarkers Market: Segmentation

On the basis of imaging techniques the neurological biomarkers market can be segment as:

Transcranial magnetic stimulation (TMS)
Diffusion tensor imaging (DTI)
Conventional structural MRI (sMRI)
Functional magnetic resonance imaging (fMRI)
Positron emission tomography (PET)
On the basis of application the neurological biomarkers market can be segment as:

Proteomics based biomarkers
Genomic based biomarkers
Imaging based biomarkers
Metabolic based biomarkers
On the basis of indication the neurological biomarkers market can be segment as:

Alzheimer's disease (AD)
Multiple sclerosis (MS)
Parkinson's disease (PD)
Autism spectrum disorder (ASD)
On the basis of end-user the neurological biomarkers market can be segment as:

Hospitals
Clinics
Diagnostic and research laboratories
On the basis of services the neurological biomarkers market can be segment as:

Sample preparation
Assay development
Biomarker validation and testing
Neurological Biomarkers Market: Region-wise Outlook

In terms of geography, the global neurological biomarkers market has been divided into five regions including North- America, Asia- Pacific and Middle-East & Africa, Latin America and Europe. North America has a major revenue share in the neurological biomarkers industry as many prominent market players are present in this region, the number of R&D projects carried out and the government funding received by academic universities to undertake research. For instance in August 2015, researchers, patients and various non-profit organizations participated in the Imaging Dementia -- Evidence for Amyloid Scanning (IDEAS) study. The USD 100 million project aims to study the utility of amyloid PET imaging to diagnose dementia, Alzheimer’s and cognitive impairment.

Asia-Pacific is the fastest growing region as the region offers huge population base, high incidence rate of neurological abnormalities, entry of new market players and huge aging population. In developing economies such as India and China, new industry players are trying to establish their market presence by developing the generic version of the biomarker, through contract research organizations. This has further helped in reducing the manufacturing cost for the company and other production related cost.

Neurological Biomarkers Market: Key Players

Key players in the neurological biomarkers industry are Myriad RBM, Proteome Sciences, QIAGEN, Thermo Fisher Scientific, AbaStar MDx, Acumen Pharmaceuticals, Abiant, Aepodia, Athena Diagnostics, ImmunArray, Quanterix and Cisbio Bioassays.

Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/16303

About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
Telephone - +1-646-568-7751
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neurological Biomarkers Market To Hold a High Potential for Growth by 2025 here

News-ID: 1056698 • Views:

More Releases from Persistence Market Resarch

Industrial Cable Reels Market is expected to increase by a CAGR of 4.0% by 2031|Key Players are Delachaux SA, Cavotec SA and more
Industrial Cable Reels Market is expected to increase by a CAGR of 4.0% by 2031| …
Trading of modern link pulls in the global market is valued at US$2,480.0 million towards the end of 2018, representing a YoY growth pace of 4.0% north of 2023. In terms of modern link reel volume, China is expected to account for almost 22.2% of the total share of the global modern link reel market towards the end of 2026 and is expected to maintain its position in the modern
Global Market for RTD/high strength premixes is poised to expand at a sub-par CAGR of 4.5% during the forecast period-2026
Global Market for RTD/high strength premixes is poised to expand at a sub-par CA …
Persistence Market Research And new report on the global RTD/high strength premixes market, RTD/High Strength Premixes Market: Global Industry Analysis (2012-2016) and Forecast (2017-2026) The study has been developed to offer valuable insights on how the demand for RTD/high strength premixes will shape up in the immediate future. Industry trends, macroeconomic factors, marketing opportunities, and new applications encompassing the global RTD/high strength premixes market have been analyzed in the report. Market
Food Retail Market Segmented By Food and Grocery Retail, Pet Food Retail in Supermarkets, hypermarkets, Independent and specialist retails, Convenience stores
Food Retail Market Segmented By Food and Grocery Retail, Pet Food Retail in Supe …
Rise in the global population, changing customer preferences and emerging economies are making the way for the food retail industry. It is a dynamically progressing industry and contributes to the development of several industries such as food packaging. Food Retail is categorized under distribution channel into four different segments: supermarkets/hypermarkets, independent and specialist retailers, convenience stores and others. Supermarket or hypermarket segment accounts for a comparatively larger market share. Increasing customer preference
Cosmetic Peptide Synthesis Market Size to Exhibit a US$ 182.1 Mn by 2032 - Insights by Persistence Market Research
Cosmetic Peptide Synthesis Market Size to Exhibit a US$ 182.1 Mn by 2032 - Insig …
The most recent report from Persistence Market Research on the worldwide cosmetic peptide synthesis market assesses the market's opportunities and current state, and it offers in-depth research and the most recent information on the relevant segments that have an impact on the market. The study provides in-depth analysis of the market's present dynamics, including its drivers, constraints, trends, and prospects. The market study's main goal is to provide unique information

All 5 Releases


More Releases for Biomarker

Transformative Trends Impacting the Multiplex Biomarker Imaging Market Landscape …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Multiplex Biomarker Imaging Market Size By 2025? In recent times, the size of the multiplex biomarker imaging market has experienced significant growth. There is an expected rise from $0.49 billion in 2024 to $0.54 billion in 2025, with a compound annual growth rate (CAGR) of
Blood-Based Biomarker Market Beyond the Needle: The Future of Diagnostics Lies i …
Blood-Based Biomarker Market worth $51.71 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Blood-Based Biomarker Market - (By Type (Screening Biomarker, Diagnosis Biomarker, Others), By Disease (Cancer, Neurological Disorders, Others), By Application (Diagnostics, Drug Discovery, Personalized Medicine)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic,
Biomarker Discovery Outsourcing Services Market Biomarker Discovery Outsourcing: …
Biomarker Discovery Outsourcing Services Market to reach over USD 52.82 billion by the year 2031 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biomarker Discovery Outsourcing Services Market Size, Share & Trends Analysis Report By Type (Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers And Surrogate Endpoints), Therapeutic Area (Oncology, Neurology, Cardiology, Autoimmune Diseases), Discovery Phase (Biomarker Identification, Biomarker Validation,
Biomarker and Companion Diagnostics Conference | Modeling Strategies for Biomark …
MarketsandMarkets presents the Immunobio Series, an extraordinary set of conferences taking place on 20-21 June 2024 in Boston, USA. Register Now @ https://events.marketsandmarkets.com/2nd-annual-biomarker-and-companion-diagnostics-conference-usa-edition/register MarketsandMarkets 5th Annual Biomarker and Companion Diagnostics Conference: Immerse yourself in the realm of biomarkers at our flagship event, where industry leaders and experts converge to propel innovation in healthcare, diagnostics, and personalized medicine. This conference serves as a dynamic platform for collaboration, knowledge sharing, and exploration of cutting-edge
Central Nervous System (CNS) Biomarkers Market Analysis Forecast 2023-2028 Globa …
The Central Nervous System (CNS) biomarkers market refers to the market for biomarkers used in the diagnosis, prognosis, and monitoring of diseases and disorders affecting the central nervous system. The central nervous system includes the brain and spinal cord, and disorders affecting this system can have significant impacts on an individual's health and well-being. CNS biomarkers are measurable indicators that can provide information about the state of the central nervous system,
Multiplex Biomarker Imaging Market - Advanced Solutions for Comprehensive Biomar …
Newark, New Castle, USA: The "Multiplex Biomarker Imaging Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Multiplex Biomarker Imaging Market: https://www.growthplusreports.com/report/multiplex-biomarker-imaging-market/8558 This latest report researches the industry structure,